Lumina Specialist Hospital — Management & Governance
The governance structure, the executive and clinical leadership, the board, the staffing model and the human-capital strategy.
Section 9 · Business Plan
Management & Governance
The governance structure, the executive and clinical leadership, the board, the staffing model and the human-capital strategy.
Lumina will be governed by an independent, appropriately skilled
board and run by an experienced executive team, with a clear separation
between corporate governance, clinical governance and day-to-day
operations.
9.1 Board & governance structure
The board will comprise the Sponsor, representatives of the strategic
and B-BBEE partners, lender-nominated or independent non-executive
directors, and the chief executive. It will operate through an Audit
& Risk Committee, a Clinical Governance Committee, a Remuneration
& Nominations Committee and an investment / capital committee,
applying the principles of the King IV Code on Corporate Governance.
Lender protections — information rights, covenant monitoring and board
observer rights — will be embedded in the finance documents.
9.2 Executive leadership
The proposed executive structure is designed for a complex acute
facility:
| Role | Mandate |
|---|---|
| Chief Executive Officer | Overall strategy, stakeholder & payer relationships, board |
| Chief Financial Officer | Funding, revenue cycle, covenant compliance, reporting |
| Chief Operating Officer / Hospital Manager | Day-to-day operations, throughput, facilities |
| Clinical Director / Medical Manager | Clinical governance, specialist relations, quality |
| Nursing Services Manager | Nursing workforce, wards, theatres & critical care |
| Commercial & Marketing Manager | Scheme contracting, referrals, brand & growth |
9.3 Clinical governance
Clinical governance is led by the Clinical Director through the
Medical Advisory Committee and its sub-committees (infection control,
pharmacy & therapeutics, theatre safety, and morbidity &
mortality review). This structure protects patient safety, supports
accreditation, and provides the board with independent assurance on
clinical quality — a prerequisite for both scheme contracting and
reputational durability.
At the date of this Plan the executive team and board are proposed
rather than fully appointed. The strength, completeness and track record
of the eventual management team are central to execution and to lender
and investor confidence; key-person arrangements and a management
incentive plan are recommended and should be confirmed before financial
close.
Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of Lumina Health Holdings (Pty) Ltd.